Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102622
Revised: November 24, 2024
Accepted: November 29, 2024
Published online: February 7, 2025
Processing time: 68 Days and 0.6 Hours
Shen et al’s retrospective study aims to compare the utility of two separate scoring systems for predicting mortality attributable to gastrointestinal (GI) injury in critically ill patients [the GI Dysfunction Score (GIDS) and the Acute Gastroin
Core Tip: In order to ensure the feasible application of scoring systems in critically ill patients, they must be simplistic and pragmatic to ensure transferability from an academic setting to clinical implementation. We propose such a modification of the current system forthwith.
- Citation: Moore S, Donlon NE. Improving gastrointestinal scoring systems for predicting short-term mortality in critically ill patients. World J Gastroenterol 2025; 31(5): 102622
- URL: https://www.wjgnet.com/1007-9327/full/v31/i5/102622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i5.102622
We were delighted to read this high-quality article by Shen et al[1] published in the World Journal of Gastroenterology. This study, retrospective in nature, looked at applying two separate scoring systems for predicting mortality attributable to gastrointestinal (GI) dysfunction in critically ill patients - namely the Acute Gastrointestinal Injury (AGI) grade and the GI Dysfunction Score (GIDS). The study involved all eligible patients admitted to an intensive care unit over a period of 3 months, yielding a total of 178 patients included for analysis.
Two attending physicians assessed each patients’ AGI grade and GIDS for the 1st week of admission, utilising elec
As noted by Shen et al[1] , the ability for critical care physicians to stratify disease severity and prognosticate short term mortality is a key clinical concern. To this end, multiple scoring systems have developed over the years to help with these issues, perhaps the most well-known and widely utilized being the APACHE II[2,3] and SOFA scores[4] , although a myriad of others do also exist.
GI dysfunction is highly prevalent in critically ill patients and is increasingly being recognised as a predictor of poor outcomes[5]. To this end, in 2012, an ESICM working group published a statement on GI dysfunction with associated terminology. This publication also gave us the AGI grade[6]. The AGI grade ranged from 1 (risk of developing GI dysfunction or failure) up to 4 (GI failure with severe impact on distant organ function).
While useful, the AGI has been criticized for its ‘subjective assessment of patient’s condition’ by none other than some of the original authors[7], who also noted that its ‘observer dependency is high’. In addition, they remark that the AGI ‘focuses on feeding intolerance – a poorly defined entity that is dependent on local feeding practices’[8].
To this end, in 2021 the GIDS was developed in an effort to provide a ‘readily available bedside score with minimised subjectivity and maximised reproducibility’[7]. This paper involved some of the same individuals involved in the original ESICM working group that produced the original AGI grading system. This GIDS system ranged from 0 (no risk of GI dysfunction) to 4 (life threatening GI dysfunction), and involved objective measures varying from the presence or lack of bowel sounds up to GI bleeding resulting in haemorrhagic shock.
Preliminary research has shown some marked discrepancies between the values obtained for a given patient when utilising AGI grade vs GIDS – with one study showing that more than 20% of patients categorised as GIDS I-II being classified as AGI III-IV[9].
In summary, GIDS was developed as a more objective approach to quantifying GI dysfunction in the critically ill, as the older AGI score was felt to be too subjective and could be influenced by other organ dysfunctions[7].
Upon reviewing Shen et al’s paper[1], we do have some observations about the manner of application of these scores to patients that may perhaps have an impact on the ultimate findings of the study. Firstly, it seems that Shen et al[1] utilised two attending physicians to assign both AGI grades and GIDS to patients included in this study. Given that one score (GIDS) has been developed to be more objective and reproducible than the more subjective AGI, we cannot help but wonder if a researcher’s assessment of the AGI could be influenced by the more objective score, they had obtained from their utilisation of the GIDS? Secondly, by comparing scores obtained for both the AGI grade and the GIDS between two attending physicians, there is potentially a danger that the inherent subjectivity of the AGI grade in particular is controlled for. This is especially true given that where such a discrepancy occurs, both physicians were required to justify their scores, with the ultimate decision for final scores resting in the hands of a third, chief or associate chief physician.
Thus, in the context of this study, the AGI grade has been subject to a high level of scrutiny by no less than three experienced physicians in circumstances where the initial assessors disagreed with each other’s findings. We feel that this level of rigor would likely be difficult to replicate in real-world situations outside of academic purposes, and that most likely the GIDS, with its less subjective approach to grading, would be easier to implement.
In order to control for this issue, we advocate that the following measures could potentially be implemented: (1) Assessment of the AGI grade be carried out by one independent physician, and the assessment of the GIDS be carried out by another. In this manner, an individual assessor would be blinded to the scores obtained from the other scoring system, which may potentially have influenced their own scores if they are tasked with performing both systems in tandem; (2) This would then also obviate the need for having a third party arbitrator in the form of the associate chief or chief physician. This would have the benefit of preserving the potential subjectivity of these scoring systems within real-world limitations; and (3) If time and/or resources allowed, having two independent physicians score the AGI grade and another two independent physicians score the GIDS would permit delineation of just how subjective the AGI grade is relative to the GIDS. If the creators of these scoring systems are correct, one might expect that the scores from indepen
1. | Shen C, Wang X, Xiao YY, Zhang JY, Xia GL, Jiang RL. Comparing gastrointestinal dysfunction score and acute gastrointestinal injury grade for predicting short-term mortality in critically ill patients. World J Gastroenterol. 2024;30:4523-4531. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (2)] |
2. | Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829. [PubMed] [Cited in This Article: ] |
3. | Mumtaz H, Ejaz MK, Tayyab M, Vohra LI, Sapkota S, Hasan M, Saqib M. APACHE scoring as an indicator of mortality rate in ICU patients: a cohort study. Ann Med Surg (Lond). 2023;85:416-421. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (1)] |
4. | Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-710. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6591] [Cited by in F6Publishing: 7507] [Article Influence: 258.9] [Reference Citation Analysis (1)] |
5. | Reintam Blaser A, Poeze M, Malbrain ML, Björck M, Oudemans-van Straaten HM, Starkopf J; Gastro-Intestinal Failure Trial Group. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med. 2013;39:899-909. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 89] [Cited by in F6Publishing: 114] [Article Influence: 9.5] [Reference Citation Analysis (1)] |
6. | Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, De Waele J, Braun JP, Poeze M, Spies C. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012;38:384-394. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 372] [Cited by in F6Publishing: 333] [Article Influence: 25.6] [Reference Citation Analysis (1)] |
7. | Reintam Blaser A, Padar M, Mändul M, Elke G, Engel C, Fischer K, Giabicani M, Gold T, Hess B, Hiesmayr M, Jakob SM, Loudet CI, Meesters DM, Mongkolpun W, Paugam-Burtz C, Poeze M, Preiser JC, Renberg M, Rooijackers O, Tamme K, Wernerman J, Starkopf J. Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients - A prospective multicenter observational study (iSOFA study). Clin Nutr. 2021;40:4932-4940. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis (1)] |
8. | Reintam Blaser A, Deane AM, Preiser JC, Arabi YM, Jakob SM. Enteral Feeding Intolerance: Updates in Definitions and Pathophysiology. Nutr Clin Pract. 2021;36:40-49. [PubMed] [DOI] [Cited in This Article: ] |
9. | Liu X, Wang Q, Yang D, Fu M, Yang M, Bi Y, Wang C, Song X. Association between Gastrointestinal Dysfunction Score (GIDS) and disease severity and prognosis in critically ill patients: A prospective, observational study. Clin Nutr. 2023;42:700-705. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Reference Citation Analysis (1)] |